The Daily Papule

Meeting abstracts

SID 2026

Society for Investigative Dermatology · Chicago, 13–16 May 2026

1,233 abstracts, published in JID on 21 July 2026. Their text is on the JID website.

  1. 0001

    CD8+ T cells are an amplifier of skin inflammation in a mouse model of atopic dermatitis

    Tukanowicz-Hassett A, Yokoyama Y, Kambayashi T

  2. 0008

    STAT3-driven immune barrier axis as a therapeutic target in atopic dermatitis

    Park H, Lee H

  3. 0012

    IL-27 promotes skin inflammation by inducing TNF-α in psoriasis and atopic dermatitis

    Chen Z, Cui L, Shi Y

  4. 0027

    Compartment-specific transcriptional profiling defines two distinct subgroups in atopic dermatitis-psoriasis overlap phenotypes

    Lee J, Chun YS, … senior author Kim J

  5. 0031

    An innovative dual-target ASO therapy targeting TSLP/STAT6 for the treatment of atopic dermatitis

    Song X, Chen H, … senior author Wang H

  6. 0032

    Periostin-expressing dermal preadipocytes amplify type-2 inflammation by guiding Th2 cell chemotaxis and adhesion in atopic dermatitis

    Guo Z, Heng S, … senior author Shi Y

  7. 0045

    Spatial neuro-immune networks of dorsal root ganglion and skin in an MC903-induced atopic dermatitis-like mouse model

    Jung Y, Kim W, … senior author Park C

  8. 0049

    Improvement of atopic dermatitis skin conditions after use of a simple formula based on extracts of aquaphilus dolomiae and broussonetia papyrifera, and dextran sulfate

    Lestienne F, Beganton B, … senior author Duplan H

  9. 0056

    Transcriptomic profiling of psoriasis and atopic dermatitis using a non-invasive dermal patch sampling platform

    Dickerson T, Lee B, … senior author Montgomery P

  10. 0100

    No taxa left behind: Discovery of enterococcus on children with atopic dermatitis

    Woods TQ, Nakatsuji T, … senior author Gallo RL

  11. 0123

    Shared genetic architecture of atopic dermatitis and food allergy revealed by multi-ancestry Trans-disease analysis

    Zhou R, Patrick M, … senior author Tsoi LC

  12. 0147

    Dermal fibroblasts modulate monocyte differentiations in atopic dermatitis

    Numata T, Hivert L, … senior author Tanaka A

  13. 0162

    Establishing a human keratinocyte-TH2 cell co-culture model to study T cell-mediated epidermal dysfunction in atopic dermatitis

    Egolf S, Coleman A, … senior author Kearley J

  14. 0179

    Efficacy of dupilumab in Chinese atopic dermatitis patients: A real-world multicentre study

    Wang R, Li H, Wang Y

  15. 0184

    Rapid paradoxical worsening after dupilumab in ICI-associated eczematous dermatitis: Two cases

    Huang J, Yang J, … senior author Shen Y

  16. 0185

    Prevalence, trends and comorbidities of atopic dermatitis in the United States from 2016 to 2023: A claims data analysis

    Huang H, Sarker J, … senior author Lee T

  17. 0211

    Emotional and behavioral challenges in children with atopic dermatitis

    Mestari Z, Zhang R, … senior author Wan J

  18. 0228

    Avon longitudinal study of parents and children multidimensional phenotyping in eczema sub-study

    Ye M, Matthewman J, … senior author Langan S

  19. 0237

    Demographic disparities and inflammatory comorbidities in ED presentations of atopic dermatitis

    Shah M, Bae G

  20. 0246

    Mental health burden in atopic dermatitis: A Colombian cross-sectional study

    Forero-Ángel C, Ordóñez-Rubiano M, … senior author Abuabara K

  21. 0254

    Genetic basis of TNF-induced atopic dermatitis: A Mendelian randomization study

    Rao S, Meng R, Li D

  22. 0258

    Cognitive performance by atopic dermatitis severity in children

    Zhang R, Xiang J, … senior author Wan J

  23. 0262

    Modeling pediatric atopic dermatitis severity with treatment-derived features

    Xiang J, Zhang R, … senior author Wan J

  24. 0268

    JAK1 selectivity is associated with a reduced risk of viral skin infections in atopic dermatitis

    Sato E, Obonai N, Imafuku S

  25. 0286

    Sleep impairment and medication use in U.S. adults with eczema: A large-scale, population-based study

    Lazarus M, Cole E

  26. 0308

    Who are we studying in TriNetX? A descriptive comparison of treatment-defined atopic dermatitis cohorts against 6 other data sources (claims, registries, surveys)

    Wong JJ, Meng L, … senior author Margolis DJ

  27. 0325

    The child eczema control tool: Preliminary results from an ongoing psychometric validation study

    Gillespie J, Fang M, … senior author Simpson EL

  28. 0331

    Dupilumab and psoriasis risk in patients with atopic dermatitis: A multicenter cohort study

    Block BR, Mehta J, … senior author Gulati N

  29. 0354

    Asteatotic eczema: A FLG mRNA low subtype as a localized pre-stage of atopic dermatitis

    Nakamoto K, Koide T, Aoyama Y

  30. 0379

    Comparative effectiveness and safety of upadacitinib versus abrocitinib for moderate-to-severe atopic dermatitis: A retrospective real world study

    Hu Y, Zhang J, Zhao Y

  31. 0385

    Comorbidities and real-world treatment patterns in seborrheic dermatitis: A large population-based cohort study

    Soto-González AM, Fuxench ZC

  32. 0389

    Dermatologist prescribing patterns for atopic dermatitis: A retrospective medicare study

    Kumar EA, Lorenz M, … senior author Wei EX

  33. 0426

    Divergent comorbidity profiles in atopic dermatitis and prurigo nodularis

    Opstal M, Gaumond SI, Jimenez D

  34. 0438

    Perceptions and fears regarding topical corticosteroids in pediatric atopic dermatitis: Insights from a caregiver survey

    Boby A, Levin BT, … senior author Silverberg N

  35. 0443

    Healthcare utilization and treatment patterns in patients with seborrheic dermatitis: A retrospective cohort study

    Meng S, Berna R, Margolis DJ

  36. 0445

    The gut-skin microbiome: A trinetX analysis between gastric ulcers and seborrheic dermatitis

    Al Rawi LN, Chen S, … senior author Farabi B

  37. 0448

    Assessing the directionality of associations between lifestyle factors, and atopic dermatitis in the UK Biobank

    Rosenblatt A, Ye M, Abuabara K

  38. 0460

    Long-term laboratory trends in patients with moderate-to-severe atopic dermatitis treated with upadacitinib: 140-week results from measure up 1 and 2

    Cotter D, Shahriari M, … senior author Irvine A

  39. 0465

    Roflumilast foam 0.3% in patients with seborrheic dermatitis and prior inadequate response, intolerance, and/or contraindications to topical antifungals and/or topical corticosteroids

    Chovatiya R, Domingues E, … senior author Stephenson B

  40. 0470

    Dupilumab treatment restores skin barrier structure and function in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis

    Cork MJ, Danby SG, … senior author Leung DY

  41. 0483

    Immunologic and clinical activity of soquelitinib, a selective ITK inhibitor, in atopic dermatitis

    Sarin K, Chiou A, … senior author Miller R

  42. 0490

    Therapeutic potential of mesenchymal stem cells therapy for moderate-to-severe atopic dermatitis: A systematic review and meta-analysis of human clinical trials

    Cueva MC, Ghanem L, … senior author Aktas S

  43. 0491

    Topical ficus awkeotsang extract for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial

    Jang C, Lin M, … senior author Hong C

  44. 0505

    Barrier-focused topical therapies in atopic dermatitis: A systematic review and meta-analysis

    Ahmad S, Prefontaine J, … senior author Ashack K

  45. 0517

    Zumilokibart (APG777), a half-life-extended monoclonal antibody, provides rapid and sustained inhibition of type 2 biomarkers in moderate-to-severe atopic dermatitis

    Guttman-Yassky E, Gooderham M, … senior author Kabashima K

  46. 0522

    Comparing lebrikizumab with other systemic immunomodulators for moderate to severe atopic dermatitis: An updated systematic review

    Alphonse C, Irfan M, … senior author Diaz AM

  47. 0532

    Real-world dupilumab outcomes in young children with atopic dermatitis

    Li A, Urbonas R, … senior author Wan J

  48. 0535

    Clinical evidence of l-histidine supplementation in atopic dermatitis: A systematic review

    Abdul-Rahman N, Choudhary S

  49. 0553

    Zumilokibart (APG777) induces rapid and robust normalization of the lesional and non-lesional atopic dermatitis skin phenotype

    Fiedler J, Zhou J, … senior author Guttman-Yassky E

  50. 0554

    The combinantion of saccharomyces and lactobacillus ferments mitigate atopic dermatitis-like phenotypes in human skin equivalents via pSTAT6 inhibition in vitro and decrease AD relapse in vivo

    Qu Y, Chen Z, … senior author Li M